FDA approves Hiberix Haemophilus influenzae type b vaccine
Links shared publicly online about this topic.
- 1,811total visits
FDA approves Hiberix Haemophilus influenzae type b vaccine
View full resource at news-medical.net
Tags: Flu, Tetanus, Meningitis, Drug, Children's Health, FDA, Vaccine, GlaxoSmithKline
Most Recently Shared on August 20, 2009 at 2:06 am By:
Meningitis News: FDA approves Hiberix Haemophilus influenzae type b vaccine: In response to a U... http://bit.ly/iCn0k
Hiberix Haemophilus influenzae type b (Hib) vaccine approved - MPR
empr.com — “The FDA has granted accelerated approval of Hiberix (Haemophilus b Conjugate Vaccine [Tetanus Toxoid Conjugate], from GlaxoSmithKline) for active immunization as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b (Hib).” View full resource at empr.com
Most Recently Shared on August 24, 2009 at 11:53 am By:
Physician Assistants Health News Feed
FDA accelerated approval of Hiberix Haemophilus b Conjugate for prevention Haemophilus influenzae type b (Hib) http://tinyurl.com/lad4hz
FDA Approves GSK's Hib Vaccine, Hiberix
drugs.com — “Hiberix (Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate)) is used for active immunization against invasive disease caused by Haemophilus influenzae type b. Includes Hiberix side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 22, 2009 at 2:52 am By:
FDA Approves GSK's Hib Vaccine, Hiberix - http://bit.ly/p0qcf
GlaxoSmithKline's Hib vaccine obtains FDA approval - Related Stories - AAP SmartBrief
smartbrief.com — “GlaxoSmithKline gained accelerated FDA clearance for Hiberix, a vaccine against Haemophilus influenzae Type B, which causes diseases such as meningitis and pneumonia. The approval allows the drug to be used as a booster in children 15 months to 4 years old and is part of an effort to address a short” View full resource at smartbrief.com
Most Recently Shared on August 21, 2009 at 9:43 pm By:
Clara Song Doctor, Pediatrician, and Physician
GlaxoSmithKline's Hib vaccine obtains FDA approval http://sbne.ws/r/2BuB
Hiberix Haemophilus influenzae type b (Hib) vaccine approved - MPR
empr.com — “The FDA has granted accelerated approval of Hiberix (Haemophilus b Conjugate Vaccine [Tetanus Toxoid Conjugate], from GlaxoSmithKline) for active immunization as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b (Hib).” View full resource at empr.com
Most Recently Shared on August 20, 2009 at 4:40 pm By:
MPR News: Hiberix Haemophilus influenzae type b (Hib) vaccine approved: The FDA has granted accelerated.. http://bit.ly/AcgkZ
Accelerated Approval of Hiberix to Help Sustain Adequate Vaccine Supply
fda.gov — “The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.” View full resource at fda.gov
Most Recently Shared on August 19, 2009 at 10:12 pm By:
eyeonfda Pharma and Health Lawyer
FDA Accelerated Approval of GSK's Hiberix to Help Sustain Adequate Vaccine Supply http://bit.ly/3rZby
Advertisement
